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Abstract
Burkholderia cepacia complex bacteria are important opportunistic pathogens in 
cystic fibrosis patients and are associated in some cases with acute necrotizing 
pneumonia, sepsis, and increased risk of death. B. cenocepacia and other Burkholderia 
are commonly found in the environment, particularly in the rhizosphere. It is not 
surprising that they have evolved high resistance against several antimicrobial agents, as 
well as the ability to interact with multiple hosts, including the ability to survive 
intracellularly in amoebae, macrophages, and epithelial cells. Like most opportunistic 
pathogens, B. cenocepacia must adapt to environmental stresses and have the ability to 
persist in the infected host. Persistence is in part associated to the bacterial ability to 
control cell division. We have identified two cell wall hydrolases, BCAL1938 and 
BCAL2128, with high sequence similarity to a Mycobacterium tuberculosis protein 
known to be essential for later stages of cell division. These proteins belong to the 
NlpC/P60 family of endopeptidases that chiefly function to modify peptidoglycan during 
growth, but are often required for cell wall turnover, separation of daughter cells during 
cell division, biofilm formation, bacterial adhesion, and motility. These proteins could 
contribute directly to B. cenocepacia pathogenicity and may also be required for revival 
from a resting state during infection. In other bacteria, including M. tuberculosis, 
NlpC/P60 proteins interact with resuscitation promoting factors (RPFs) that mediate 
resuscitation from a dormant state. B. cenocepacia mutant strains not expressing 
BCAL1938 and BCAL2128 show growth defects characterized by aggregation of cells 
and the formation of long chains. BCAL2128 mutant strains are sensitive to high osmotic 
pressure, oxidative stress, detergents, and cell-wall acting antibiotics. BCAL1938 mutant
iii
strains have a defect in O antigen production and are sensitive to polymyxin. We also 
have evidence that these predicted NlpC/P60 proteins are able to degrade peptidoglycan 
in vitro and thus might be involved in cell wall remodeling. Therefore, the potential 
necessity and non-redundancy of these proteins in B. cenocepacia during adaptive 
responses make them novel putative targets for antimicrobial drug development.
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Chapter 1: Introduction
1.1 Cystic Fibrosis
Cystic fibrosis (CF) is the most common fatal genetic disorder in Caucasian 
populations [1] that results from a defective membrane-bound chloride ion channel 
named CF transmembrane regulator (CFTR) [2]. CFTR normally transports chloride out 
of the cell; its dysfunction results in increased sodium intake which leads to dehydration 
of the airway mucosal layer [3]. The sticky mucous in CF lung patients interferes with 
normal mucociliary clearance, which impairs innate immunity and ultimately leads to 
chronic infection [4]. Although complications associated with CF can occur in several 
organs, over 90% of CF patients die from respiratory failure following complications of 
chronic lung infections [5].
Pulmonary infection begins in infancy and young CF patients are usually infected 
with Haemophilus influenzae and Staphylococcus aureus [6]. As patients approach 
adolescence, approximately 80% are infected with Pseudomonas aeruginosa [1]. P. 
aeruginosa colonization initially occurs with non-mucoid strains but, over time, the 
bacteria almost always become mucoid, which leads to a drastic increase in resistance to 
multiple antibiotics. Consequently, treatment and eradication of infection is a complex 
procedure involving combinations of repeated and aggressive antibiotic regimes. 
Improved treatment strategies have increased CF patient lifespans, but of recent concern 
for CF patients is the opportunistic human pathogen Burkholderia cepacia.
2
1.2 Burkholderia species.
Burkholderia species are among the most versatile groups of Gram- negative 
bacteria [7] because they can occupy a wide range of ecological niches including soil, 
water (both fresh and saline), rhizosphere, animals and humans [8]. B. cepacia complex 
(Bcc) is a group of genetically similar, but phenotypically different environmental species 
of B. cepacia recovered from approximately 10% of CF patients (9). B. cepacia was first 
identified as a plant pathogen but other Bcc organisms are useful for promoting plant 
growth and bioremediation [9]. Bcc can also survive in hospital environments including 
hand wash disinfectants, intravenous fluids and even distilled water [7]. Such diversity 
suggests that Burkholderia sp. are highly adaptive bacteria, which could explain why they 
are intrinsically resistant to several antibiotics and antimicrobial peptides [10].
Bcc organisms cause severe pulmonary infection in CF patients and persistence 
can sometimes develop into “cepacia syndrome”, a severe infection characterized by 
rapid, necrotizing pneumonia often leading to death [1]. Bcc is also highly associated 
with chronic granulomatous disease (CGD), a rare genetic disorder involving impaired 
oxidative killing by host immune cells [11]. Bcc organisms are highly resistant to 
antibiotics and their genome encodes diverse virulence factors that are required to avoid 
clearance by the host and promote infection. Infecting bacteria can also be transmitted 
between patients [12] and in many centers, patients infected with Bcc are rarely 
considered as candidates for lung transplantation due to the increased risk of death post­
transplantation caused by Bcc sepsis [13].
There are at least 17 species belonging to the Bcc [14] all of which are able to
infect CF patients [15]. B. cenocepacia was the most common isolate found in CF
3
patients from Canada and the United Kingdom [16]. B. cenocepacia strain J2315 is one 
isolate that belongs to the ET12 lineage. Its 8.06-megabasepair genome was recently 
sequenced [17] revealing three chromosomes and a plasmid. Infection with ET12 clones 
has been associated with cepacia syndrome and increased mortality [18]. B. cenocepacia 
has been the model species for extensive studies to better understand the underlining 
mechanisms involved in CF infection. However, B. multivorans is now the most common 
Bcc isolate in America and in the United Kingdom [19].
1.3 Gram Negative Cell Envelope
Bcc are aerobic, non-fermenting Gram-negative bacilli. One structural component of the 
cell envelope of Gram-negative bacteria is the outer membrane. This is a unique 
asymmetric bilayer of which the lipopolysaccharide (LPS) accounts for the majority of its 
outer leaflet while phospholipids predominate in its inner leaflet (Fig. 1). The LPS 
structure varies among organisms but, in general, the molecule consists of the core 
polysaccharide, the O-polysaccharide (also referred to as O-antigen) and the Lipid A, the 
latter being important for activation of host innate immune systems [20]. LPS interacts 
with outer membrane proteins and divalent cations and these interactions help maintain 
the structural integrity of the outer membrane [21]. The outer membrane is impermeable 
to large molecules and serves as a barrier for proteins and other large molecules present 
in the periplasm. The periplasm is located between the inner leaflet of the outer 
membrane and outer surface of the cytoplasmic membrane and contains a thin 
peptidoglycan (PG) layer.
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Figure 1. The Gram-negative cell envelope. LPS molecules are embedded in the outer 
leaflet of the outer membrane. The thin PG layer in the periplasm is between the outer 
and inner membrane. Many proteins are embedded in the outer membrane, such as 
integral membrane proteins (blue), porins (red) and lipoproteins (green). Numerous 
proteins localize to the periplasm (purple) and are involved in various processes, 
including the control of cellular morphology by modulating the PG layer.
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1.4 Peptidoglycan
PG is a mesh-like sacculus that protects the bacterial cell. This stress-bearing cell- 
wall layer is a highly conserved heteropolymer of glycan chains composed of alternating 
TV-acetylglucosamine (GlcNAc) and A-acetylmuramic acid (MurNAc) residues linked 
together by a p -1,4 glycosidic bond. Linear glycan chains are cross-linked together by 
pentapeptide chains that extend from the C3 lactyl moiety of MurNAc residues, creating 
a three-dimensional network of peptides and glycans (Fig. 2). For Gram-negative 
bacteria, the PG layer is typically built up of 1 to 3 glycan strands, where as the cell wall 
of Gram-positive bacteria is up to 90% PG [22], Gram-negative bacteria and Gram­
positive Bacilli peptides are bonded between the meso-diaminopimelic acid (m-DAP) and 
D-alanine residues, and the majority of other Gram-positive bacteria contain L-lysine and 
D-alanine peptide linkers [23]. The PG sacculus is not a static structure as it constantly 
undergoes reorganization during cell growth and division or cell lysis/invasion by 
bacteriophage enzymes [24]. During these events, the wall is disassembled through the 
action of a diverse set of lytic enzymes that cleave different linkages in the PG layer.
Such enzymes include glycosidases that hydrolyze the glycan backbone, and peptidases 
that degrade the cross-linking peptides [25]. Enzymatic activity often results in the 
release of PG fragments (muropeptides) that can be recycled back into the cytoplasm 
where PG is continuously being synthesized. The amount of PG shedding and turnover 
varies amongst microorganisms but generally speaking, for both Gram-positive and 
Gram-negative bacteria, over 50% of PG is shed for each generation of bacteria [26]. 
Gram-positive bacteria PG fragments are released to the extracellular environment due to 
the absence of an outer membrane. However, in Gram-negative bacteria only about 5% of
6
Figure 2. Structure diagram of DAP-type peptidoglycan. NlpC/P60-type 
endopeptidases typically cleave the peptide bond between the meso-diaminopimelic acid 
and glutamate residue on the peptide chain (purple arrow) where as lytic 
transglycosylases cleave the p~ 1,4 -glycosidic bond between the sugar residues (black 
arrow).
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the PG muropeptides are secreted extracellularly, half of which are recycled back into the 
cell [27]. Extracellular muropeptides may act as signaling molecules to monitor growth 
conditions [28] and may also be detected by host innate immune systems [29] via Nodi 
and Nod2 receptors [29, 30]. Thus, an inert state of growth can be beneficial for survival 
of intracellular pathogens.
1.5 Dormancy and Other Non-growth States
1.5.1 Defining Dormancy
The ability of microorganisms to thrive in diverse and often hostile environments 
is essential for their survival. When faced with stressful and often unpredictable 
environmental conditions, bacteria have ways to adapt and survive. For pathogenic 
bacteria, including B. cenocepacia, adaptation is also critical for persistence and 
pathogenesis. The ability of bacteria to enter a low or inactive metabolic state is one 
common adaptation response that enables both survival and, in some cases, retention of 
pathogenesis. In a laboratory environment, this state is often referred to as ‘viable but 
nonculturable’ (VBNC) because the bacteria are alive but fail to grow under normal 
standard culturing conditions [31]. In a clinical setting, these cells can also be described 
as ‘persister cells’; bacterial cells that show tolerance to antibiotics instead of relying on 
resistance mechanisms [32]. To circumvent specific terminology, these reversible states 
are generally described as ‘dormancy’; a global slowdown of metabolic activity where 
bacterial cells are in a non-dividing, often unculturable state [23, 32]. Dormant cells
allow bacteria to thrive in hostile environments and may also be responsible for causing 
latent infections within a host.
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1.5.2 Virulence of VBNC Cells
Despite controversy over whether or not cells in a VBNC state are avirulent, there 
is direct evidence that bacterial virulence is retained during a low metabolic state and that 
infection can be initiated following resuscitation [33]. Several known human pathogens 
exist in a dormant state. Some examples include Bacillus anthracis and Clostridium 
difficile, both capable of producing dormant resistant spores [34]. Mycobacterium 
tuberculosis represents an important example of bacteria that can survive in human hosts 
in a low replicative state for decades [28]. This dormant state represents latent infections 
in TB patients, and the return of TB after several years of apparent cleared infection is the 
result of the bacteria resuscitating from a VBNC state [35, 36].
The fundamental problems with treating VBNC bacteria include their structural 
differences that permit evasion of regular host immune responses, their increased 
resistance to antimicrobials, and their undetectable presence using standard culturing 
conditions.
Entering a VBNC state is not simply a survival strategy for pathogenic bacteria as 
many environmental organisms survive in the same manner. For example, Vibrio 
vulnificus and Pseudomonas fluorescens enter a dormant state to live long-term in aquatic 
and soil environments, respectively. In fact, the list of both pathogenic and non- 
pathogenic bacteria that can exist in a VBNC is steadily increasing as the medical and 
environmental implications are becoming more apparent.
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1.5.3 Evidence of VBNC Burkholderia
From the Burkholderia genus, both Bcc and B. pseudomallei have been 
discovered in a VBNC state in the environment [31]. B. pseudomallei is one of the few 
human pathogens of the Burkholderia genus and it is the causative agent of melioidosis, a 
lung-associated disease that is endemic in southeast Asia [37]. Similar to Bcc, B. 
pseudomallei also survives and replicates within immune cells. However, it can exist in a 
dormant state within hosts for several years and cause latent infection [38]. These 
highlighted similarities between the two species of Burkholderia beg the question as to 
whether or not Bcc organisms can also exist in infected patients for an extended period of 
time, thereby causing a latent infection. It has been difficult, however, to find evidence 
that supports this hypothesis. The relatively recent awareness and low frequency of Bcc 
infection, in addition to the severity of infection (often leading to mortality), could 
explain why Bcc latent infections have yet to be observed.
1.5.4 Intracellular Survival of B. cenocepacia
In the environment, Bcc organisms frequently live as endosymbionts within plant 
tissue and develop commensal interactions with their host [1]. However, they also 
habitually reside within plant tissue as well as eukaryotic organisms (e.g. amoebae and 
nematodes) and cause infection. As Bcc organisms are opportunistic pathogens not 
associated with human flora, infected humans most likely acquired Bcc from the 
environment as a result of both their immunocompromised state and Bee’s ability to 
adapt to several niches [39]. Bcc members survive within a membrane-bound vacuole in 
mammalian respiratory epithelial cells and phagocytes, an observation also made during
Bcc infection of free-living amoebae [40, 41]. These Bcc-containing vacuoles (BcCVs) 
have a delayed fusion with lysosomes [42], delayed assembly of NADPH oxidase on 
their membrane [43], and display reduced acidification of the BcCV lumen [44]. These 
postponed events must occur for Bcc intracellular survival and it is reasoned that the time 
delay facilitates bacterial gene activation that render the microorganisms resistant to host 
immune responses [41]. For example, Bcc bacteria survive in the presence of toxic 
oxygen compounds by producing catalase enzyme [45]. The oxidative burst of host 
inflammatory response cells is the first line of defense against pathogens, and Bee’s 
resistance might be important for bacterial survival within the host.
In epithelial cells, Bcc bacteria eventually enter the endoplasmic reticulum and 
initiate replication [46]. Conventional intracellular survival assays rely on the use of 
gentamicin, and until recently it was difficult to monitor Bcc replication within immune 
cells due to the bacteria’s high antibiotic resistance. However, an aminoglycoside- 
sensitive B. cenocepacia strain (MH1K) has been constructed in our laboratory [47] and 
was used to confirm intracellular replication of Bcc within macrophages. Such 
intracellular survival strategies contrast with B. pseudomallefs survival mechanism that 
involves escape from endocytic vacuole fusion all together, and instead replicates freely 
within the host cell cytosol [48].
1.5.5 Inducing the Formation of VBNC Bacteria
Several factors such as nutrient starvation, toxic chemicals, non-optimal 
temperatures and changes in osmotic pressure can stimulate bacteria to enter a VBNC 
state [23, 31]. Bacteria respond to such inducers in several ways but no matter the
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circumstance, there is always a notable decrease in metabolism [49]. However, 
development of resting cells is not a cost-free process since the structural transition into 
and out of a dormant state requires the involvement of a substantial amount of cellular 
machinery [50]. Some of these changes are readily observable such as a reduction in cell 
size, or a larger physical change like, for example, the formation of endospores. Other 
less obvious phenotypic changes can occur such as a reduced size of DNA precursor 
pools, reduced protein content, altered lipid compositions, a less energized cell 
membrane, accumulation of storage components, and several ultrastructural changes [49]. 
The PG layer of dormant cells is often manipulated and influences the state of non­
growing cells [28]. These changes are inconsistent among species, one example being the 
lowered level of peptide cross-linking between glycan strands seen in endospores [51] 
compared to the increased levels of cross-linking detected in E. coli VBNC cells [52]. 
Despite such variations, there is agreement that the PG layer is indeed modified.
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1.5.6 Exiting from a VBNC State
The circumstances that lead to organisms exiting a dormant state are even less 
understood. In several cases, normal cell growth will recommence if regular culturing 
conditions are resumed or nutrients become available again [53]. For many bacteria, the 
supernatant of growing cells can be used to recover dormant bacterial growth. For 
example, B. subtilis spores will germinate in the presence of PG fragments found in the 
supernatant of actively diving cells [54]. This process is thought to occur by extracellular 
receptors that bind muropeptides and initiate a signaling cascade favoring growth. Gram­
negative bacteria have an outer membrane and thus cannot respond to extracellular 
substances in the same manner. However, it is apparent that some level of assessment 
occurs to evaluate whether environmental conditions are sufficient to re-initiate growth 
[55]. One important factor during this process is the resuscitation-promoting factor (Rpf) 
proteins.
12
1.6 Resuscitation- Promoting Factors
1.6.1 Discovery of RRF Proteins
Mukamolova et al. discovered the first member of the RPF family in Micrococcus 
luteus in 1998 [56]. Rpf from M. luteus is an essential, secreted 17-kDa protein that is 
able to reactivate stationary phase and dormant cultures. The addition of recombinant Rpf 
to cultures results in increased numbers of colony forming units (CFUs), decreased 
growth lag time, and promotes growth in medium that is not normally permissive for 
culturing VBNC cells [57]. Rpf can also stimulate growth of aged M. tuberculosis 
cultures and recover growth of M. tuberculosis in murine macrophages [35, 58]. M. 
tuberculosis was later found to produce five RPFs (RpfA-Rpffi) and these have also been 
extensively studied. Although there is redundancy between the genes, deletion of rpfB 
alone causes delayed reactivation in a mouse model of infection [59]. Members of the 
RPF family are found throughout the Actinobacteria and Firmicute species [60, 61], and 
there is some evidence that RPF-like families also exist in Gram-negatives species [62].
As M. luteus Rpf is a secreted protein, it must induce its growth stimulatory 
effects from an extracellular location, an event that is not likely to occur in Gram­
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negative bacteria due to the presence of the outer membrane. In Gram-positive bacteria, 
it is thought to associate with the cell wall through its PG-binding LysM-type domain 
[57], and possibly be involved in the cell wall remodeling process that must occur for 
cells to exit from a non-growth state. This correlates with the observed function of Rpf, 
which has been shown to possess muralytic activity by acting on the glycan backbone of 
the PG layer [63]. Rpf acts on the (3-1,4 glycosidic bond between the MurNAc and 
GlcNAc residues, which is the same site of cleavage of lysozyme and lytic 
transglycosylases (Fig. 2). Not surprisingly, crystal structures of Rpf and one of the five 
M. tuberculosis Rpf homolog, RpfB, indicate that the catalytic domain exhibits a 
lysozyme-like fold and contains a transglycosylase-like domain [64, 65].
1.6.2 RPF Mechanism of Action
RPFs were once thought as being cytokines that bind to a receptor to initiate a 
growth signaling response [56]. To date, however, no receptors have been identified. As 
RPFs appear to have muralytic activity, one of the two current hypotheses for their action 
is that they function directly to overcome the physical requirements for initiating VBNC 
cell expansion and division [63]. The composition of PG changes during transition to a 
VBNC state [28] so perhaps RPFs only exert their enzymatic activity on inert cell walls. 
However, other PG hydrolase enzymes, such as lysozyme, are not capable of stimulating 
dormant bacteria [63] suggesting that RPF activity, along with other unknown additional 
processes, are required to resuscitate the bacteria. The second prevailing hypothesis is 
that RPF proteins breakdown PG to produce muropeptides acting as secondary 
messengers for downstream signaling, much like p- lactamase induction [66]. A few 
muropeptide receptors have been identified such as the serine/threonine kinase receptor
PrkC, which binds extracellular muropeptides from germinating B. subtilis spores [54].
As PG is extremely well-conserved, muropeptides would also have the potential to serve 
as interspecies signals that indicate when conditions are suitable for supporting microbial 
growth [23].
1.6.3 Potential B. cenocepacia RPFs
BLAST searches for RPF homologs in B. cenocepacia have failed using the M 
luteus and M. tuberculosis Rpf proteins as the queries. The B. cenocepacia gene with the 
highest protein sequence similarity to Rpf is bcalJ952. It shares low sequence identity (< 
10%) to Rpf but is predicted to encode a LysM domain. There are no annotated B. 
cenocepacia genes that encode the characteristic transglycosylase-like domain that is 
conserved in Gram-positive RPFs. There are a few B. cenocepacia genes that encode 
putative lytic transglycosylase enzymes, but there is no indication that these are involved 
in PG remodeling processes aside from the housekeeping cellular processes in which lytic 
transglycosylases are normally required for. To date, the only Gram-negative RPF that 
has been characterized is from Salmonella enterica sv. Typhimurium (accession number 
AY772265). This rpf-like gene has 24% amino similarity to Rpf, although it does not 
have a transglycosylase-like domain (Fig. 3). Instead, it belongs to the COG1214 
superfamily of proteins considered to be inactive homologs of metal-dependent proteases 
and/or putative molecular chaperone proteins [67]. Regardless, recombinant forms of the 
protein resuscitated S. Oranienburg cells that were previously induced by osmotic stress 
to enter a VBNC state [62]. The B. cenocepacia strain K56-2 chromosome encodes two 
hypothetical proteins belonging to the COG1214 family of proteins. These genes are 
located on chromosomes 1 and 2 and were annotated as bcam0913 and bcal2115A by the
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Wellcome Trust Sanger Institute (http: //www.sanger.ac.uk/ Projects/Bcenocepacia/). 
They share 32% and 38% amino acid sequence identity to the S. enteric rpf-like protein, 
respectively.
1.6.4 RPF Interacting Proteins
Although RPFs stimulate growth on their own, investigators have shown that 
synergistic hydrolysis of PG will occur when RPF-interacting proteins (RIPs) are present. 
RipA from M. tuberculosis was the first identified RIP protein that was shown to interact 
with RpfB [68]. This family of lipoproteins are cysteine peptidases that interact with 
RPFs and colocalize to the septum of dividing cells [69]. However, RIPs alone are not 
sufficient to waken dormant cells. Recently it has been shown that RipA also interacts 
with another PG metabolizing enzyme, penicillin binding protein 1 (PBP1) [70]. PBPs 
are involved in cell wall synthesis and remodeling events that are required for normal cell 
division and modification processes. PBP1 from M. tuberculosis will also colocalize with 
RipA to the septum of dividing cells, but its activity inhibits synergistic hydrolysis of PG 
caused by the RipA-RpfB complex [70]. This suggests that RPF-RIP activity is a 
regulated system.
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Figure 3. Amino acid alignments of hypothetical B. cenocepacia RPF. Residues in 
bold denote identity between two of the three sequences and those highlighted in yellow 
are invariable. Abbreviations of the RPFs (and accession numbers) are: Bceno, B. 
cenocepacia BCAL2115a (YP 002231242); Sent, S. enterica subsp. enterica Rpf 
(AAX08053); MLuteus rpf, M  luteus Rpf (CAB09664).
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1.7 NlpC/P60 Superfamily
1.7.1 Rip A and Other Characterized Proteins Belonging to the NlpC/P60 Family
RipA is a cysteine peptidase predicted to be an endopeptidase due to the presence of a 
signature NlpC/P60 domain. Bacterial enzymes belonging to the NlpC/P60 protein
domain family are all cysteine peptidases (MEROPS peptidase clan CA, family C40) and 
are predicted to be both secreted and membrane-bound lipoproteins [71]. In general, 
members of this class are involved in PG modification, and those that have been 
characterized have y-D-glutamyl-DL- endopeptidase activity [72]. The family 
nomenclature is based on the E. coli lipoprotein NlpC and the Listeria monocytogenes 
protein p60, but other characterized members include the B. subtilis LytE and LytF 
autolysins, L. monocytogenes p45, E. coli Spr, and Streptococcus PcsB protein [25, 71, 
73-76]. Disruption of genes encoding NlpC/P60 proteins causes defective cell division 
resulting from improper daughter cell separation [72]. This growth defect is characterized 
by the formation of long chains and can sometimes lead to reduced virulence in vivo [77- 
79].
1.7.2 Structural Features of NlpC/P60 Proteins
NlpC/P60 superfamily domains adopt a papain-like secondary structure (Fig. 4) 
and are frequently fused to an N-terminal signal peptide, a MurNAc amidase, and 
sometimes various targeting domains such as the LysM domain and the bacterial SH3b 
domain [72]. The active site is positioned near the interface between the NlpC/P60 and 
targeting domain, which may contribute to substrate specificity, allowing only specific
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Figure 4. The predicted protein structure of BCAL2128. The structure was 
constructed by Rita Berisio (Institute of Biostructures and Bioimaging, Naples, Italy) and 
modeled after the M. tuberculosis NlpC/P60 endopeptidase, RipA. The three amino acids 
that form the conserved cysteine protease catalytic triad are labeled.
19
muropeptides to bind the active site [80]. Only the P60-type subfamily members contain 
a LysM domain, which are general PG binding modules with a unique secondary 
structure with the two a- helices located on the same side of the anti- parallel p sheet 
[81]. The M  tuberculosis NlpC/P60 endopeptidase, RipA, only comprises a NlpC/P60 
domain and a Spr hydrolase domain
1.7.3 Conserved Catalytic Triad of NlpC/P60 Peptidases
The second a-helix of the NlpC/P60 domain is conserved and contains the 
cysteine residue located at the amino terminus, and is often preceded by a polar residue 
[80]. The central motif contains a conserved glycine residue, and the two invariant his 
histidine residues that are part of the Cys-His-His catalytic triad [82]. The nucleophilic 
cysteine residue attacks the peptide bond and the proton transfers occur by the histidine 
residues acting sequentially as the base then acid catalyst [72].
1.7.4 B. cenocepacia NlpC/P60 Peptidases
There are two genes in B. cenocepacia strain K56-2 that encode predicted 
NlpC/P60 domains (Fig. 5). The first gene product, BCAL1938 (accession number 
YP 002231066.1) is 361 amino acids in length and shares 35% sequence identity to 
RipA. It is also annotated as a Spr hydrolase with a predicted lipoprotein cleavage site. 
The NlpC/P60 domain is predicted to be closer to the N-terminus of the protein (amino 
acids 68-175) in contrast to the typical C-terminal location. The predicted molecular 
weight of BCAL1938 is 38 kilodaltons (kDa). The second NlpC/P60 homolog, 
BCAL2128 (accession number YP 002231255.1) is 224 amino acids in length and shares 
32% sequence identity to RipA. It is annotated as a Spr hydrolase but does not have a
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Figure 5. Alignment of “Spr” regions of hypothetical Cys peptidases predicted to be 
cell wall-associated hydrolases (invasion-associated proteins). The C-terminal half of 
the sequences presented (denoted by arrow) are identified members of the NlpC/P60 
family of proteins. Residues in bold denote identity between two of the three sequences, 
those highlighted in yellow are invariable. The Cys residue in red is the postulated 
catalytic residue of the putative cysteine peptidase. Abbreviations (and accession 
numbers) are: Be CysP A, B. cenocepacia BCAL2128 (YP 002231255.1); Be CysP, B. 
cenocepacia BCAL1938 (YP 002231066.1); Mt, M. tuberculosis invasion protein RipA 
(NP_215993.1).
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predicted lipoprotein cleavage site. The NlpC/P60 domain is predicted to be located 
between amino acids 88-195, and has a predicted molecular weight of 25 kDa.
1.8 Research Proposal
Based on the apparent involvement of RPF and RIP proteins for resuscitation of 
dormant M. tuberculosis cultures, the fact that both M. tuberculosis and B. cenocepacia 
are intracellular pathogens associated with severe lung tissue damage, and the ability of 
M. tuberculosis to also cause latent infections, we hypothesize that RIP homologs found 
in B. cenocepacia may be important for cell wall remodeling adaptation responses. The 
purpose of my research was to study the two predicted NlpC/P60 homologs of RipA (Fig. 
6) and investigate their importance for B. cenocepacia survival and replication under 
normal conditions, as well as various stress conditions. My aim was to determine whether 
or not these homologs functioned as endopeptidases, which would suggest their 
requirement for cell wall remodeling and their potential involvement in resuscitation of 
dormant B. cenocepacia in infected patients. To address my hypothesis, I had three 
specific aims. The first was to determine whether these proteins have PG hydrolytic 
activity.The second was to create mutant strains that do not produce BCAL1938 and 
BCAL2128 and test their ability to survive and replicate in vitro, and lastly, to elucidate 
the biological role of BCAL1938 and BCAL2128.
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Figure 6. Genomic location of bcall938 and bcal2128. The predicted functional 
domains of neighboring genes are labeled.
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Chapter 2: Material and Methods
2.1 Strains and culture conditions. E. coli and B. cenocepacia strains used in this study 
are described in Table 1. Strains grew at 37 °C in liquid Luria Bertani (LB) broth or on an 
LB plate containing 1.6% Bacto Agar. Trimethoprim (50 pg/mL for E. coli or 100 
pg/mL for B. cenocepacia) was used for selection of mutants. Tetracycline (20 pg/mL for 
E. coli or 100 pg/mL for B. cenocepacia) was used for selection of mutants and 
maintenance of complementing plasmids. Kanamycin (40 pg/mL) and ampicillin (100 
pg/mL) were used for selection of plasmids used for protein expression in E. coli. 
Gentamicin (50 pg/mL) or polymyxin (25 pg/mL) was used during triparental mating to 
select against donor and helper strains.
The murine macrophage-like cell line RAW 264.7 was grown and maintained at 
37°C with 5% CO2 in DMEM supplemented with 10% fetal bovine serum.
2.2 Isolation of B. cenocepacia chromosomal DNA. Bacterial strains were subcultured 
in LB media and grown overnight at 37°C with agitation. The following morning, 500 pi 
of culture was centrifuged at 13 000 x g, washed once with sterile water, and the cell 
pellet was resuspended in 500 pi SET buffer (25 mM NaCl, 25mM EDTA, 20 mM Tris- 
HC1 pH 7.5) supplemented with 1% SDS, 0.1 mg/mL RNase, 0.2 mg/mL Proteinase K 
and 0.2 mg/mL lysozyme. The mixture was incubated at 37°C for 24 hours with 
agitation using a Labquake®. Following incubation,
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Table 1. Strains used in study.
Strain Genotype Source or reference
Escherichia coli
DH5a F" (p80 lacZAU\5 A(lacZYA-argF)U169 endAl 
recAl hsdR17 (rjc” niK*) supE44 thi-1 AgyrA96 
relAl
Laboratory stock
SY327 araD A (lac pro) argE(Am) recA56 rifR nalA, \  pir 
lambda pir
[83]
GT115 F  mcrA D(mrr-hsdRMS-mcrBC) <p 80lacZDM15 
DlacX74 recAl rspL (StrA) endAl A dcm uidA(A 
ML ul): :pir-116 A sbcC-sbcD
Invivogen
BL21 (DE3) F -  ompT hsdSB(vB~, mB-) gal dcm (DE3) Laboratory stock
Burkholderia cenocepacia
K56-2 ET12 clone, CF clinical isolate BCRRC
MH1K K56-2, Abcall674-bcall676 [47]
X0A11 K56-2, arnT under control of P rha promoter, TpR [84]
CLC5 K56-2, bcal2128 under control of P rha promoter, TpR
This study
CLC10 K56-2, bcall938 under control of P rha promoter, TpR
This study
CLC22 K56-2, Abcall938 This study
CLC23 K56-2, Abcal2128 This study
CLC25 CLC22, Abcal2128 This study
CLC36 MH1K, Abcall938 This study
CLC37 MH1K, Abcal2128 This study
CLC38 CLC36, Abcal2128 This study
a 700 pi of a chloroform: isoamylalcohol mixture (24:1), was added, mixed thoroughly, 
and the DNA preparation was collected by centrifugation at 13 000 x g  for 10 minutes. A 
300 pi sample of the upper phase was transferred to a fresh microtube and 600 pi of cold 
isopropanol was added. The DNA was allowed to precipitate for 1-5 hours at -20 °C 
before being recovered by centrifugation as before. The resulting DNA pellet was washed
2- 3 times with 70% ethanol before being resuspended in sterile water. The purity and 
concentration of DNA was measured using a nanodrop spectrophotometer (Thermal 
Scientific).
2.3 Preparation and transformation of E. coli potassium chloride competent cells.
Overnight cultures of E. coli DH5a, BL21 (DE3), GT115 and SY327 strains were 
subcultured (1/20 dilution) in 50 mL of fresh LB for 2 hours at 37°C. The cultures were 
chilled on ice for one hour and the cells were harvested by centrifugation at 4°C. The cell 
pellet was resuspended in 20 mL cold filter-sterilized solution A (30 mM KAc, 100 mM 
KC1, 10 mM CaCl2, 50 mM MnCh, 15% glycerol pH 5.8) and centrifuged at 9500 x g  at 
4°C for 15 minutes. The pellet was resuspended in 5 mL of cold filter-sterilized solution 
B (10 mM MOPS, 10 mM CaCh, 100 mM KC1, 15% glycerol pH 6.5) and left on ice for
3- 10 hours. Cells were aliquoted into sterile microtubes (100 pi aliquots) and stored at - 
80°C. Frozen cells were thawed on ice prior to the addition of DNA for transformation. 
Cells were then incubated on ice for an additional 30 minutes and heat shocked at 42°C 
for one minute. Viable cells were recovered at 37°C for 30-60 minutes in LB broth and
plated on the appropriate selection media.
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2.4 Conditional Mutant Strategy for Essential Genes
2.4.1 Cloning of conditional mutant deletion plasmids. All plasmids used and created 
are described in Table 2, while all primers used are listed in Table 3. B. cenocepacia 
conditional mutants were constructed using the rhamnose-inducible promoter, pSC200. 
Approximately 300 bp of the 5’ end of bcall938 and bcal2128 were PCR amplified from 
B. cenocepacia K56-2 chromosomal DNA using primer pairs 4629/4670 and 4622/4620, 
respectively. Resulting amplicons were digested with Ndel and Xbal, followed by 
overnight ligation with appropriately digested vector. Ligation products were introduced 
into the E. coli lambdapir strain SY327 and recovered on media containing trimethoprim 
and 0.2% rhamnose. Plasmids containing proper insertion of gene fragments were 
screened by PCR, verified by sequencing, and named pCC7 and pCC5.
2.4.2 Construction of mutant strains CLC5 and CLC10. Conditional mutant plasmids 
were transferred into B. cenocepacia K56-2 by conjugation. Overnight cultures of the 
donor strain (K56-2), recipient strains harboring pCC7 or pCC5, and the E. coli helper 
strain containing the pRK2013 plasmid were centrifuged and cell pellets were washed 
three times with sterile PBS. Cells from each strain were mixed together in 100 pi of LB, 
plated on LB agar, and incubated at 37°C for 24 hours. The cell mixture was serially 
diluted and plated on LB agar containing trimethoprim, gentamicin and 0.2% rhamnose. 
Colonies were screened by PCR and positive clones were named CLC5 and CLC10.
2.4.3. Checking essentiality of BCAL1938 and BCAL2128. CLC5 and CLC10 grew 
overnight in LB containing either 0.2% rhamnose or 0.2% glucose and 1 mL of culture 
was centrifuged at 16 000 x g  for 1 minute. Pellets were washed three times in PBS, and
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Table 2. Plasmids used in study.
Plasmid Genotype Source or reference
pET28a(+) IPTG inducible expression vector; KmR Novagen
pRK2013 RK2 derivative, mob+, tra , o r / coiE i, KmR [85]
pDA17 oripBBKU mob+, Pdhfr, FLAG epitope, TetR [86]
pGPI-Scel o r / R 6 K ,  I-SceI endonuclease recognition site, 
mob+, TpR
[87]
pDAI- Seel pDA17, Saccharomyces cerevisiae I-Scel, TetR [87]
pDA-mRFPICT pDA17, mRFPl, TetR Lab stock*
pGEX-2T O ripB B R l, gSt, ApR GE Life Sciences
pSC200** oriR 6 K ,  Prha (rhamnose inducible) promoter, 
rhaRS, TpR
[84]
pCC3 pGPI-Scel, 500 bp 5’ and 600 bp 3’ fragments 
of bcall938, TpR
This study
pCC4 pGPI-Scel, 500 bp 5’ and 600 bp 3’ fragments 
of bcal2128,TpR
This study
pCC5 pSC200, 300 bp bcal2128 5’ fragment, TpR This study
pCC7 pSC200, 300 bp bcall938 5’ fragment, TpR This study
pCC9 pDA17, bcal2128, TetR This study
pCC15 pDA-mRFPICT, bcall938-mRFPl, TetR This study
pCC16 pDA-mRFPICT, bcal2128- mRFPl, TetR This study
pCC17 pDA17, bcal!938, TetR This study
pCC20 pET28a(+),bcall938, KmR This study
pCC21 pET28a {+),bcal2128,KmR This study
pCC22 pET28a(+),bcal2128t, KmR This study
pCC25 pET28a (+),bcall952, KmR This study
pCC28 pET28a(+),bcall938t, KmR This study
pCC30 pET28a(+),èca/2775^, KmR This study
Constructed by Daniel Aubert, **previously referred to as pSC201
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Table 3. Primers used in this study. Restriction enzyme cut sites are underlined.
Primer Sequence (5’ to 3’) Restriction Enzyme Site
4478 CCGC ACG A ATT CTCGGGGGGGC AGC EcoRl
4479 TCAGGGATCGATGCTGCATTGGTCG Clal
4480 ATCGACATCGATGCGACGATCGGCGACGATTC Clal
4481 GCTT AGJCTAGATCGT GC AGCGT GCCGTCGGT G Xbal
4620 GAGGCCCGAATCCGTCTAGAGCGAGTTGC Xbal
4621 GCTAAGTCTAGATCAGTTGTTGCCGTTCGC Xbal
4622 GTTATCCATATGCAGCATCGATCCCTGAC Ndel
4623 CTACTAGAATTCGTGCTGCAGAAGACCGACG EcoRl
4625 GTCGTAATCGATTCGCGCGTAAACTGCG Clal
4626 GTTACTAATCGATGTTGCTCGACCCCGAC Clal
4627 GCT AAGT CT AG AGT AC AGCCT GGGCC AC Xbal
4629 GTTACTCATATGCTTCGAATCTGG Ndel
4669 GCGACTCATATGCTTCGAATCTGGGTTCC Ndel
4670 CGCTCGTCTAGATTCGATCGACACGCCGCG Xbal
4672 CGAGCCAAGCTTTCAGTAACTGCCGGTCGC Hindlll
4791 GTTCTACCATGGTCATGCAGCATCGATCCC Ncol
4792 GTTACTCCATGGTCATGGCCGACGAAGTC Ncol
4793 CGTACTCGAGGTTGTTCGTTCGCCGAATC Xhol
4794 CGCTACCATGGTCATGCTTCGAATCTGGG Ncol
4795 GTACTCCATGGTGATGGCATCGCGCTCCGC Ncol
4796 GACGTACTCGAGGTAACTGCCGGTCGCAAAC Xhol
4834 ATAAGTCTAGAGTAACTGCCGGTCGCAAACC Xbal
4835 AGATGTCTAGAGTTGTTGCCGTTCGCCG Xbal
5159 GAT AT AT CC AT GGGT CTT CTTT CG Ncol
5160 CTTATACTCGAGGGACTGCGGCGGAATC Xhol
5204 GT ATT ACC AT GG AT AT GCGC AC AG ATCG Ncol
5379 CCGCTCGAGTCATCCCTTCGCTCCGCC Xhol
diluted to an optical density at 600 nm of 1.0. Ten-fold serial dilutions were plated on a 
semi-defined minimal medium [84] containing 0.5% rhamnose or 0.5% glucose and 
incubated at 37°C for 24 hours.
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2.5 Unmarked Gene Deletion Strategy
2.5.1 Cloning of gene deletion plasmids. Upstream and downstream regions of 
bcall938 and bcal2128 were PCR amplified from B. cenocepacia K56-2 chromosomal 
DNA using primers 4623—>4627, and 4478—>4481, respectively. PCR products were 
restriction enzyme digested, ligated as a triple ligation into pGPI-Scel, and transformed 
into GT115 competent cells. Colonies were screened by PCR and positive clones were 
confirmed by sequencing.
2.5.2 Construction of deletion strains CLC22, CLC23 and CLC25. Deletion plasmids 
pCC3 and pCC4 were transferred into B. cenocepacia strain K56-2 by conjugation as 
previously described. Exconjugants were selected by plating on LB agar containing 
trimethoprim and gentamicin. Isolated colonies were used to inoculate overnight cultures 
in LB medium. A second conjugation event was conducted between the exconjugant 
strains and an E. coli strain containing plasmids pRK2013 and pDAI-Scel. Selection was 
performed on solid medium supplemented with tetracycline and gentamicin (or 
polymyxin). Colonies were screened by PCR and trimethoprim sensitivity was confirmed 
before the pDAI-Scel vector was resolved by plating on LB agar supplemented with 5% 
sucrose. Colonies that were tetracycline sensitive were streaked on agar plates and the 
presences of the correct insertions were confirmed by PCR, resulting in strains CLC22
and CLC23. As CLC22 was generated first, it was used as the recipient strain for the 
construction of the double deletion mutant strain, CLC25.
2.5.3 Construction of deletion strains CLC36, CLC37 and CLC38. Deletion plasmids 
pCC3 and pCC4 were transferred into B. cenocepacia strain MH1K by conjugation as 
previously described. The first set of exconjugants were selected by plating on LB agar 
containing trimethoprim and polymyxin, and the second round of exconjugants were 
selected on solid medium supplemented with tetracycline and polymyxin. Colonies were 
screened as previously described and positive clones were named CLC36 and CLC37. As 
CLC36 was created first, it was used as the recipient strain for the construction of the 
double deletion mutant strain, CLC38.
2.6 Complementation of CLC22, CLC23 and CLC25. bcall938 and bcal2128 were 
PCR amplified from B. cenocepacia K56-2 DNA using primer pairs 4669/4670 and 
4622/4621, respectively. PCR products were digested with restriction enzymes before 
being ligated to digested pDA17 and transformed into DH5a competent cells. Colonies 
were screened and sequenced as previously described. Resulting plasmids, pCC9 and 
pCC17, were transferred by conjugation into CLC22 and CLC23, respectively. Both 
plasmids were also transferred into CLC25.
2.7 Phase-contrast light microscopy. Bacterial cultures grew overnight in 5 mL of LB 
broth at 37°C with agitation. Cultures were diluted to an OD600 of 0.1 and growth was 
resumed for 24 hours. At each growth stage (stationary phase, early exponential phase,
late exponential phase, stationary phase and late-stationary phase), 10 pi of culture was 
removed and placed on a glass slide coated with 1% agarose. If necessary, cultures were 
diluted with fresh LB medium to better visualize individual cells. Live cell images were 
obtained using an Axioscope 2 (Carl Zeiss) microscope with a 1 OOx oil immersion 
objective lens coupled to a Q imaging Retiga-SRV camera.
2.8 Generation of growth curves. Overnight cultures of strains were diluted to OD600 of 
0.05 and transferred to a 100-well honeycomb plate (300 pl/well). The plate was 
incubated at 37°C with continuous shaking and growth was monitored for 24-48 hours by 
OD600 every 30-60 minutes using a Bioscreen C automated microbiology growth curve 
analysis system (Oy Growth Curves AB Ltd.). For growth curves with antibiotics, 
polymyxin, sodium chloride, hydrogen peroxide and SDS, varying volumes of stock 
solutions were added to 1 mL of diluted cells. For low pH growth curves, cells were 
diluted in LB medium buffered with Tris-MES and the pH was adjusted with 
hydrochloric acid. All growth curves were performed in triplicate.
2.9 Live/Dead viability measurement. Cell viability was determined using the 
LIVE/DEAD® RacLight Bacterial Viability kit as per manufacturer’s instructions 
(Invitrogen). Overnight cell cultures were adjusted to an OD6ooof 0.5 and centrifuged for 
one minute at 16 000 x g. Cell pellets were washed three times with PBS and 
resuspended in a final volume of 250 pi PBS. Equal volumes of dye (SYTO 9 and 
propidium iodide) were added to the cells and incubated in the dark for 15 minutes.
Live/dead ratio of cells was either enumerated using epifluorescence microscopy or 
counted using a FACS Calibur with CellQuest Pro acquisition software (Becton 
Dickinson). Data analysis was done via FlowJo (Tree Star, Inc.). All results were 
normalized against heat-killed B. cenocepacia parental cells combined at a 1:1 ratio with 
live cells.
2.10 Intracellular survival assay. Raw 264.7 macrophages were infected with parental 
MH1K, CLC36, and CLC37 strains (Table 1) and growth and survival was monitored for 
48 hours post-infection. Bacteria were washed twice with DMEM plus 10 % fetal bovine 
serum and adjusted to an OD600 of 1.0. Macrophages were seeded overnight onto twelve- 
well tissue culture plates and bacteria were added at a multiplicity of infection (MOI) of 
25, centrifuged at 300 x g  and incubated for one hour at 37°C under 5 % CO2. Bacteria 
not taken up by the macrophages were removed by three washes with PBS followed by 1 
hour incubation in DMEM supplemented with 100 pg/mL gentamicin. The gentamicin 
was removed by two washes in PBS, and the macrophages were incubated in DMEM 
supplement with 10 pg/mL gentamicin for the remaining duration of the experiment. To 
monitor bacterial uptake and survival within the macrophages, 300 pi of 0.1% sodium 
deoxycholate was added to each well to lyse the macrophages, and bacteria were plated 
on LB agar for CFU enumeration. Each experiment was performed in triplicate.
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2.11 Cellular localization of proteins, beali938 and bcal2128 were PCR amplified from 
B. cenocepacia K56-2 chromosomal DNA using primer pairs 4834/4672, and 4835/4621,
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respectively. The PCR products were digested for 2 hours with the appropriate restriction 
enzymes and ligated into digested pDA-mRFPICT. The resulting plasmids, pCC15 and 
pCC16, were transferred into B. cenocepacia by conjugation (as described earlier). For 
live-cell imaging, overnight cultures were sub-cultured 1/100 and grown for 3 hours at 
37°C. 500 pi of culture was pelleted by centrifugation at 13 000 x g  and resuspended in 
20 pi of LB medium or in 20 pi of 25 mM HEPES pH 7.4 containing 50% sucrose. Cell 
samples were immobilized on a glass slide coated with a thin, dried layer of 1% agarose 
dissolved in 15% sucrose to maintain plasmolysis. Live cells were visualized by 
fluorescence microscopy as previously described.
2.12 Protein Studies
2.12.1 Cloning of expression plasmids. Genes of interest were amplified by PCR using 
B. cenocepacia K56-2 chromosomal DNA as template. For cloning of full length and 
truncated (lacking the N-terminal signal sequence) bcall938, primer pairs 4794/4796 and 
4795/4793 were used, respectively. For cloning of full length and truncated bcal2128, 
primer pairs 4791/4793 and 4792/4793 were used, respectively. For cloning of bcaI1952, 
primers 5159 and 5160 were used. For bcal2115A, primers 5204 and 5379 were used. 
Amplified genes were purified using a QIAquick PCR purification kit (Qiagen) followed 
by digestion with the appropriate restriction enzymes. Digested products were ligated to 
digested pET28a(+) plasmid DNA and transformed into E. coli DH5a competent cells. 
Transformants were screened by PCR for the correct insertion size and plasmids were
isolated using a QIAprep spin miniprep kit (Qiagen). Plasmids were sequenced to 
confirm nucleotide sequence identity.
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2.12.2 Overproduction and purification of proteins. For overexpression of genes and 
the overproduction of proteins, E. coli BL21(DE3) freshly transformed with plasmid 
DNA was inoculated into LB broth supplemented with 40 pg/mL kanamycin and 
incubated at 37 °C until early exponential phase (OD600 of 0.4 - 0.6). Isopropyl 0-D-1- 
thiogalactopyranoside (IPTG) was added to a final concentration of 1 mM and expression 
was induced for 5 hours at 30°C. Cells were collected by centrifugation (9500 x g  for 10 
min at 4 °C) and if required, stored at -20 °C. Cell pellets were resuspended in lysis 
buffer (50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, lOmM imidazole) 
containing EDTA-free protease inhibitor mixture tablets, 10 pg/mL RNase A, 5 pg/mL 
DNase I and 2 pg/mL lysozyme and kept on ice for 30 minutes. Cells were lysed using a 
cell disrupter (Constant Systems Ltd.) and the resulting cell lysate was centrifuged (40 
000 x g  for 20 minutes at 4 °C) to remove cellular debris. The soluble protein fraction 
was collected and incubated with Ni - charged Sepharose (1 pi resin/mL original culture 
volume) on a Labquake® for 1 hour at 4 °C. The resin slurry was transferred into a 
disposable column and the flow-through was collected. To remove contaminating 
proteins, the column was washed with 1 column volume of lysis buffer followed by 5 
column volumes of lysis buffer containing 20 mM imidazole, 1 column volume of 50 
mM imidazole buffer and 1 column volume of 100 mM imidazole buffer. Purified 
protein was eluted with 5 mL of 250 mM imidazole buffer. The imidazole and other salts 
were removed from the protein sample by overnight dialysis in 25mM sodium phosphate 
buffer pH 7.0.
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2.12.3 Bradford protein assay. Protein concentrations were determined by the 
colorimetric Bradford assay [8 8 ]. In a 1.5 mL cuvette, 200 pi of Bradford reagent (Bio- 
Rad) was mixed with 800 pi of sterile water and 5 pi of standard or protein sample was 
added. The absorbance was measured at 595 nm. Bovine serum albumin (BSA) standards 
ranging from 0.025 mg/mL to 1.0 mg/mL were used to compute the extinction coefficient 
and calculate the concentration of the recombinant protein samples.
2.12.4 SDS-PAGE and Western immunoblotting. Protein samples were analyzed by 
SDS-PAGE analysis using the method of Laemmli [89]. Briefly, protein samples were 
mixed with the appropriate amount of loading sample buffer (50 mM Tris-HCl pH 6 .8 , 
2% SDS, 10% glycerol and 0.1% bromophenol blue) and boiled for 5 minutes. The 
samples were then loaded onto a 15% SDS - polyacrylamide gel and subjected to 
electrophoresis for 2 hours at 120 volts. The gels were either stained with Coomassie 
Brilliant Blue R-250 or transferred to a nitrocellulose membrane following standard 
procedures. Membranes were blocked for 1-24 hours using 5% Western blocking solution 
(Roche) made in TBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl). After 3 washes with 
TBS, the His6-tagged proteins were detected using a 1:1000 dilution of a commercially 
available mouse (Amersham) or rabbit (Rockland) anti-His6 followed by a 1:2000 
dilution of Alexa fluor 680 IgG goat anti-mouse (Invitrogen) or Alexa fluor 800 IgG goat 
anti-rabbit (Rockland) secondary antibody. Reacting bands were detected by 
fluorescence with the Odyssey infrared imaging system (Li-cor Biosciences).
2.13 Preparation of insoluble substrate. An overnight culture of B. cenocepacia K56-2 
was subcultured (1/20 dilution) and grown for 4 hours at 37°C with shaking. Cells were
pelleted at 9500 x g  and stored at -20°C until a sufficient mass was accumulated 
(approximately 20 litres of culture). The cell mass was resuspended in 200 mL of buffer 
(25mM sodium phosphate buffer pH 6.5) and transferred to a round bottom flask. SDS 
was added at a final concentration of 4%, and the mixture was boiled under reflux with 
stirring for 3 hours. Once complete, the solution was centrifuged at 164 000 x g  for 1 
hour in an ultracentrifuge. The supernatant was discarded and the PG pellet was washed 
three times with buffer. A final wash was made with sterile water. The PG pellet was 
treated with 200 pg/mL Pronase for one hour at 60°C, followed by treatment with 100 
pg/mL a- amylase, lOpg/mL DNase, 50 pg/mL RNase. 20 mM MgS04 was added and 
the mixture was incubated at 37°C for an additional 16 hours. The reaction was 
terminated by boiling under reflux for 15 minutes in a 4% SDS solution, and the purified 
PG was collected by centrifugation at 164 000 x g. After washing three times with sterile 
water, the final pellet was resuspended in 10 mL of sterile water, briefly sonicated, and 
lyophilized. The resulting dehydrated PG was stored at -20°C. In total, 100 mg of PG was 
isolated and purified from 20 L of starting culture.
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2.14 LPS analysis. B. cenocepacia LPS was extracted as previously described [90]. 
Overnight cultures were adjusted to an OD600 of 2.0 and centrifuged at 16 000 x g  for 1 
minute. Pellets were resuspended in 150 pi lysis buffer (2% SDS, 4% /?-mercaptoethanol, 
0.5 M Tris pH 6.8) and boiled for 10 minutes. Proteinase K was added at a final 
concentration of 0.2 mg and suspensions were vortexed and incubated at 60°C for 2 
hours. Next, 150 pi of pre-warmed 95% phenol was added and samples were incubated at 
70 °C for 15 minutes (vortexed every 5 minutes) followed by a 10 minute incubation on
ice. Samples were centrifuged for 10 minutes at 16 000 x g  and the aqueous phase was 
transferred to another tube. 500 pi of ether was added to eliminate any remaining traces 
of phenol and the sample was again centrifuged at 16 000 x g for one minute. The ether 
phase was aspirated off and 10 pi of sample was added to protein sample buffer for 
analysis in a 14% Tricine SDS- PAGE gel followed by silver staining.
2.15 PG Lytic Assays
2.15.1 Zymography. Zymograms for lytic activity were performed using purified 
insoluble B. cenocepacia PG as substrate. The PG (0.1% final concentration) was co­
polymerized in a 15% polyacrylamide gel and samples were subjected to electrophoresis 
as previously described. Following electrophoresis, the gel was washed in sterile water 
for 30 minutes with shaking, and then incubated at 37 °C in renaturing buffer (20 mM 
sodium phosphate pH 7.0, 10 mM MgC^ 0.1% Triton X-100) for 48 hours with mild 
shaking. Cleavage of PG was visualized following staining with 0.1% methylene blue 
dissolved in 0.01% KOH [91].
2.15.2 Turbidometry. The turbidometric assay of Hash [92] was used to monitor PG 
degradation by purified recombinant protein samples. Purified B. cenocepacia PG was 
resuspended in 50 mM sodium acetate pH 6.5, and subjected to brief sonication. Purified 
proteins (0-20 pg) were added to 1 mL aliquots of 0.4 mg/mL substrate suspension, and 
the decrease in turbidity of the reaction mixtures was monitored continuously at OD660 
for a period of 30-120 minutes.
2.15.3 FITC-release assay. Fluorescein isothiocyanate (FITC) was covalently linked to 
the free amines of B. cenocepacia K56-2 PG. PG was suspended in 2.5 mL of 0.1 M 
NaC03 pH 9.0 at a final concentration of 5 mg/mL. The PG was then added slowly to a 2 
mg/mL solution of FITC (dissolved in DMSO) and incubated overnight at 4°C on a 
Labquake®. The FITC-PG was mixed with 0.1% xylene cyanol and 5% glycerol (final 
concentrations) and then recovered by centrifugation at 48 000 x g  for 20 minutes. The 
pellet was washed three times in PBS to remove unbound FITC. The resulting FITC - 
labeled PG was stored in PBS at 4°C.
Lytic reactions were performed in 2 mL tubes. FITC-PG (500 pi of a 1 mg/mL 
suspension) was added to 400 pi of 50 mM Tris-HCl buffer, pH 5.75, containing 10 mM 
MgCL, 2 mM MnCL, 100 mM KH2PO4, and 0.01% Triton X-100. Samples (10-20 pg) of 
BCAL1938 or BCAL2128 were added to the buffered substrate and incubated for 3 days 
at 37°C. Reactions were terminated by centrifugation at 16 000 x g  for 5 minutes. The 
supernatant was removed and its absorbance at 485 nm was measured. FITC-PG 
incubated with buffer alone was used as a negative control and 2 pg of lysozyme was 
used as a positive control.
2.16 PG binding assay. A PG pull-down assay [93] was used to determine the ability of 
BCAL1938 and BCAL2128 to bind insoluble PG. Purified protein samples (15 pg) were 
incubated with 1 mg/mL insoluble B. cenocepacia PG in 25 mM sodium phosphate 
buffer pH 6.0 for 1 hour at 4 °C on a Labquake®. The insoluble PG was collected by 
ultracentrifugation (164 000 x g  for 30 minutes at room temperature) and was washed
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three times with buffer to remove unbound material. The washed pellet was suspended in 
a 4% SDS solution at room temperature for 1 hour to extract bound protein. Each fraction 
(supernatants, washes, and SDS extract) was analyzed by SDS-PAGE and Western blot 
using an anti-His6 antibody.
2.17 Induction and Resuscitation of VBNC cells
2.17.1 Temperature-shift induction. 1 mL of overnight cultures of B. cenocepacia 
strains were used to inoculate 10 mL of LB broth. Cells were incubated for 24 hours at 
37°C and then transferred to a 20°C incubator with very gentle agitation. Cultures 
remained at 20°C until they entered a VBNC state (7-12 days). Viability was assessed 
using the LIVE/DEAD® itacLight Bacterial Viability kit as per manufacturer’s 
instructions (Invitrogen) and percent survival was determined by calculating the average 
live/dead ratio of approximately 1000 cells. Culturability was monitored by plating 100 
j l i I  of culture on LB agar every 2 days and incubating for 48 hours at 37°C.
2.17.2 Osmotic-shock induction. Cultures of B. cenocepacia strains were prepared as 
above and following incubation for 24 hours at 37 °C, cells were harvested by 
centrifugation at 3000 x g. Cells were washed three times in PBS and approximately 1010 
cells were resuspended in 50 mL of LB broth supplemented with 7% NaCl (final 
concentration) and incubated at 37 °C for 3-5 days. Viability and culturability were 
monitored as described above
2.17.3 Resuscitation of VBNC cells. Bacterial cells in a VBNC state were resuscitated 
by transfer to fresh LB broth (1/10 dilution) containing 25 pg of filter-sterilized
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recombinant protein or 2 0 0  pi of filter-sterilized supernatant from exponentially growing 
B. cenocepacia K56-2 cells (positive control).
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Chapter 3: Results
3.1 Growth of bcall38 and bcal2128 mutant strains during normal culturing 
conditions
3.1.1 BCAL1938 and BCAL2128 expression is not essential for B. cenocepacia 
survival. My initial hypothesis was that BCAL1938 and BCAL2128 are essential for B. 
cenocepacia survival given that several members of this family of enzymes are required 
for viability in other bacteria. To address this, conditional mutant strains CLC5 and 
CLC10 (table 1) were generated and tested for their ability to grow on minimal medium 
under permissive (rhamnose) and non-permissive (glucose) conditions. XOA11 is a 
conditional mutant of an essential gene required for LPS synthesis [84] and it was used 
as a positive control. As anticipated, XOA11 grew well on minimal medium 
supplemented with rhamnose, but it had impaired growth under repressing conditions 
(glucose). However, both CLC5 and CLC10 grew equally well in the presence of either 
rhamnose or glucose (Fig. 7), indicating that bcall938 and bcal2128 genes are not 
required for survival.
3.1.2 Deletion of bcal2128 causes abnormal cellular division and irregular cell 
morphologies. To determine if lack of bcall938 and bcal2128 gene expression would 
result in phenotypic changes similar to those observed in other organisms, unmarked 
gene deletion strains were prepared that did not express individual genes, and a mutant 
strain that did not express both genes. Deletion strains were generated instead of using 
the previously constructed conditional mutants to preclude a concern with possible
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Figure 7. BCAL1938 and BCAL2128 are not essential B. cenocepacia K56-2 genes.
CLC5 and CLC10 grew overnight in LB containing either 0.2% rhamnose or 0.2% 
glucose, washed three times in PBS, and diluted to an optical density at 600 nm of 1.0.
10 pi of ten-fold serial dilutions were drop-plated on minimal medium (MM) containing 
0.5% rhamnose or 0.5% glucose and incubated at 37°C for 24 hours. XOA11 was 
previously shown to be essential for B. cenocepacia K56-2 survival (82) and was used as 
a positive control.
influences the presence of selection marker antibiotics would have on observed 
phenotypes. Single deletion strains for bcall938 (CLC22) and bcal2128 (CLC23) grew 
similar to parental B. cenocepacia strain K56- based on growth curves generated by 
monitoring the optical density of cultures grown in an automated Bioscreen (Fig. 8). The 
double deletion strain, CLC25, grew well in the first 20 hours of incubation but then 
gradually decreased in turbidity. I hypothesized that the decline in optical density was the 
result of cells clumping together and sedimenting to the bottom of the plate. To study 
this, and other possible phenotypic differences, deletion strains grew in LB broth and 
cells from each growth stage were analyzed by phase-contrast microscopy. Parental B. 
cenocepacia cells had normal phenotypes and cellular morphology during lag phase, 
exponential phase, and stationary phase (Fig.9a, 10a, 11a). CLC22 cells grew similarly to 
parental cells through each growth stage (data not shown) but CLC23 and CLC25 cells 
did not. During lag/early exponential phase, CLC23 and CLC25 cells appeared swollen 
and short chains of cells were observed (Fig. 9b, 9c). By exponential phase, CLC23 cells 
remained linked together and often by asymmetric division planes (Fig. 10b). Very long 
chains (over 50 cells linked together) were also frequently observed (Fig. 10b inset). 
CLC25 cells were clumped together, often had an irregular shape, and also formed 
chains, albeit not to the extent of CLC23 cells (Fig. 10c). Stationary phase CLC23 and 
CLC25 cells continued to show abnormal cell morphologies (Fig. l ib , 1 lc) in 
comparison to typical stationary phase cells (Fig. 1 la) and numerous CLC25 cells 
appeared to have lysed . To confirm cell death, stationary phase cells were stained using 
the LIVE/DEAD® staining kit and analyzed by flow cytometry. As predicted, the ratio of 
live to dead cells was higher for parental cells in comparison to CLC25 after 48 hours of
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Figure 8. BCAL1938 and BCAL2128 activity is not essential for B. cenocepacia K56- 
2 survival. Growth curves for parental B. cenocepacia strain K56-2 and NlpC/P60 
mutant strains were generated using a Bioscreen C automated growth curve reader. Each 
time point represents the mean and standard error of three replicates.
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Figure 9. CLC23 and CLC25 cells are unable to divide normally during lag phase.
Phase-contrast microscopy of B. cenocepacia parental K56-2 strain (A), CLC23 (B) and 
CLC25 (C) cells viewed at a total magnification of lOOOx
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Figure 10. CLC23 and CLC25 cells undergo morphological changes during 
exponential phase. Phase-contrast microscopy of B. cenocepacia parental strain K56-2 
(A), CLC23 (B) and CLC25 (C) cells viewed at a total magnification of lOOOx.
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Figure 11. CLC23 and CLC25 cells do not recover by stationary phase. A : Phase- 
contrast microscopy of B. cenocepacia parental strain K56-2 (A), CLC23 (B) CLC25 (C) 
cells viewed at a total magnification of lOOOx. B: Flow cytometric analysis of K56-2 and 
CLC25 stationary phase cells stained with a mixture of SYT09 and propidium iodide.
growth (Fig. 1 lb), and parental cells were 30% more viable than CLC25. To ensure that 
the observed phenotypes were due to the absence of bcal2128 expression, complementing 
plasmids were constructed that expressed BCAL2128 (pCC9) or BCAL1938 (pCC17). 
Attempts to complement CLC23 and CLC25 with pCC9 were successful (Fig. 12b, 12c) 
as normal division and morphology were restored. CLC25 complementation by pCC17 
did restore growth phenotypes to a small extent (Fig. 12d), indicating that there might be 
some redundancy between the proteins.
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3.2 B. cenocepacia NlpC/P60 Enzyme Requirement During Conditions of Stress
3.2.1 CLC23 cells are highly susceptible to high osmotic pressure. The abnormal 
growth phenotypes observed by CLC23 and CLC25 cells suggested that BCAL2128 
expression may be required when the bacteria are stressed. To test this, growth of the 
deletion strains was monitored under several different stressful conditions. The first 
condition tested was high osmotic pressure induced by an increase in salt concentration in 
the growth medium. Both K56-2 and CLC22 cells were unaffected by high osmotic 
pressure (Fig. 13c). CLC25 cells grew relatively well for the first 18-24 hours, followed 
by a slow decline in optical density (Fig. 13c). This unusual growth curve was an 
exaggeration of CLC25 cells under normal conditions (Fig. 8). Complementation of 
CLC25 with pCC9 was sufficient to generate a growth curve similar to K56-2 cells (Fig. 
13d) with the exception of a delayed lag phase. CLC23 cells were highly affected by the 
increase in osmotic pressure and they could not grow in the presence of 500mM NaCl 
(nearly 6 times the salt concentration of LB) for at least 24 hours (Fig. 13c), if not at all
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Figure 12. BCAL2128 mutant phenotype can be complemented. A mobile plasmid 
expressing BCAL2128 was transferred into CLC23 and CLC25 by conjugation. Phase- 
contrast microscopy of B. cenocepacia parental strain K56-2 (A), CLC23- pCC9 (B) 
CLC25-pCC9 (C) and CLC25-pCC17 (D) at lOOOx total magnification.
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Figure 13. CLC23 and CLC25 grow poorly under high osmotic pressure. Growth 
rates of cultures in 172 mM (A), 344mM (B) and 500mM NaCl (C, and D) media. 
Growth was monitored in a Bioscreen C automated growth curve reader. Each time point 
represents the mean and standard error of three replicates.
(Fig 13d). The observed growth phenotype for CLC23 cells could be titrated, where 
increasing the salt concentration prolonged the lag phase of growing cells (Fig. 13b, 13c). 
CLC23 growth rates returned to wild-type levels after complementation with pCC9 (Fig. 
13d). To address whether or not the decreased growth rate of CLC23 was a reflection of 
poor survival in a high osmotic environment, CLC23 viability in 500 mM NaCl was 
monitored for 12 hours. K56-2 recovered much better than CLC23 as CFU counts after 
the 12 hour incubation were almost 2 logs higher for wild-type cells (Fig. 14). 
Furthermore, Live/Dead staining revealed that K56-2 cultures had 25% more viable cells 
(based on intact cytoplasmic membranes) than CLC23 cultures (Fig. 14).
3.2.2 CLC23 and CLC25 are sensitive to oxidative stress. Oxidative stress induced by 
hydrogen peroxide was also examined because B. cenocepacia is normally resistant to 
reactive oxygen species produced by host immune cells during respiratory burst. Cultures 
of K56-2 and CLC22 grew normally in the presence of hydrogen peroxide at 
concentrations ranging from 0.5 -  1.5 mM (Fig. 15a, 15c, data not shown for CLC22). At 
2 mM hydrogen peroxide, however, K56-2 did not grow until after 24 hours (Fig. 15b). 
The delayed growth of K56-2 either may indicate cell recovery from oxidative damage or 
represents subpopulations of cells that adapted to the presence of hydrogen peroxide. 
CLC23 and CLC25 cells were unable to grow in the presence of 1.5 mM hydrogen 
peroxide (Fig 15a, 15c) and growth recovery was not detected after 24 hours (Fig. 15b), 
suggesting that cells not expressing BCAL2128 did not respond in the same manner as 
K56-2. Growth of CLC23 and CLC25 in 1.5 mM hydrogen peroxide was restored 
following complementation with pCC9 (Fig. 15c).
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Figure 14. B. cenocepacia K56-2 survives better than CLC23 during conditions of 
osmotic stress. Strains were cultured in LB broth until an OD600 of 1 -0 was reached, and 
then transferred to medium supplemented with 5% NaCl. Growth (CFU enumeration) and 
viability (Live/Dead fluorescence staining) was monitored for an additional 12 hours. 
Each time point represents the mean and standard error of three replicates.
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Figure 15. BCAL2128 mutants are sensitive to oxidative stress. Cell cultures were 
grown in the presence of 0.5mM H2O2 (A), 2 mM H2O2 (B) and 1.5 mM H2O2 (C). 
Growth was monitored in a Bioscreen C automated growth curve reader. Each time point 
represents the mean and standard error of three replicates.
3.2.3 CLC23 and CLC25 cells have compromised cell envelopes. I hypothesized that 
the irregular cell morphologies of CLC23 and CLC25 observed under the microscope 
was caused by defects in cell envelope integrity. To test this hypothesis, the growth of 
deletion strains in the presence of detergent was compared to parental cells. As expected, 
both parental K56-2 and CLC22 cells grew well in medium supplemented with 0.02% 
SDS, but both CLC23 and CLC25 had decreased rates of growth under the same 
conditions (Fig. 16a, 16c). Increasing the SDS concentration to 0.03% had a minor effect 
on the growth of K56-2 cells but did not increase the sensitivity of CLC23 cells. In 
contrast, CLC25 cells did not grow in 0.03% SDS (Fig 16b) but growth could be restored 
by complementation with pCC9 (Fig. 16c).
3.2.4 Loss of BCAL1938 expression results in increased sensitivity to polymyxin. To
test whether the instability of the cell membrane was due to LPS modification, CLC22, 
CLC23, and CLC25 strains were grown in the presence of polymyxin B. Growth of K56- 
2 and CLC23 was unaffected in medium supplemented with up to 1000 pg/mL 
polymyxin B, whereas CLC22 and CLC25 cells grew poorly (Fig. 17a, 17b). Thus, 
CLC22 and CLC25 sensitivity increased as the concentration of polymyxin in the 
medium increased from 0-1024 pg/mL (Fig. 17d, CLC25 data not shown) compared to 
K56-2 growth under the same conditions (Fig. 17c). Complementation of both strains 
with pCC19 successfully restored parental resistance to polymyxin (Fig. 17b).
3.2.5. BCAL1938 is required for proper LPS synthesis. To confirm B. cenocepacia 
BCAL1938 mutant strain sensitivity to polymyxin was caused by altered LPS synthesis, 
LPS from each strain was extracted, run on an LPS gel, and silver stained. The banding
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patterns observed on the gel for K56-2 and CLC23 LPS were identical, where as unique 
banding patterns were observed for CLC22 and CLC25 LPS preparations (Fig. 18). A
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Figure 16. The cell envelope integrity of CLC23 and CLC25 cells is weaker than 
parental strain K56-2. bcal2128 mutant strains are more sensitive to SDS at 
concentrations of 0.02% (A and C) and 0.03% (B). Growth was monitored in a Bioscreen 
C automated growth curve reader. Each time point represents the mean and standard error 
of three replicates.
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Figure 17. BCAL1938 mutants are more sensitive to polymyxin than K56-2. Cell 
cultures grew in the presence of 500 pg/mL (A) and 1000 pg/mL (B) polymyxin B. K56- 
2 grew normally in the presence of 0-1024 pg/mL polymyxin (C) but CLC23 sensitivity 
could be titrated (D). Growth was monitored in a Bioscreen C automated growth curve 
reader. Each time point represents the mean and standard error of three replicates.
larger fraction of the LPS appeared to consist of core oligosaccharide attached to the 
Lipid A and in the case of CLC22 cells, there was a large band that represents Lipid A 
core oligosaccharide with one O antigen unit attached. The bands corresponding to 
polymeric O antigen of CLC22 and CLC25 cells migrated faster in the gel, indicating that 
the length of polymeric O antigen is shorter for these cells in comparison to K56-2. 
Production of polymeric O antigen could be partially complemented by pCC19, but not 
by pCC7, as higher bands were detected in both complemented CLC22 and CLC25 
fractions, and the single O antigen band was no longer present. However, the band 
corresponding to Lipid A oligosaccharide remained unaltered.
3.2.6 B. cenocepacia has increased sensitivity to antibiotics when BCAL2128 is not 
produced. As BCAL2128 and BCAL1938 are predicted to be involved in cell wall 
remodeling, I hypothesized that the loss of gene expression would render B. cenocepacia 
susceptible to cell-wall acting antibiotics. B. cenocepacia cells lacking BCAL2128 had 
increased sensitivity to carbenicillin (Fig. 19) and imipenem (Fig. 20a, 20b, 20c) 
compared to parental cells, but not to ampicillin or methicillin (data not shown). The B. 
cenocepacia MIC for carbenicillin is > 400 pg/mL and CLC23 sensitivity was detected at 
125 pg/mL. CLC23 did not change when concentrations of this p-Lactam were increased 
to 250 pg/mL. CLC25 did not become sensitive to carbenicillin until the concentration 
reached 250 pg/mL. Sensitivity to carbenicillin for both CLC23 and CLC25 did not 
increase beyond the concentration of 250 pg/mL. CLC23 and CLC25 sensitivity to 
imipenem was detected at 25 pg/mL (0.4 x MIC) and both strains did not grow for over
24 hours in the presence of 50 pg/mL imipenem. CLC23 and CLC25 sensitivity to 
imipenem disappeared by complementation with pCC9 (Fig. 20d), but sensitivity to
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Figure 18. LPS synthesis of CLC22 and CLC25 is altered. The LPS of B. cenocepacia 
strains was prepared by phenol extraction and run on a 14% Tricine SDS-PAGE gel. The 
gel was fixed and the LPS fractions were visualized by silver staining. Asterisks denote 
the area on the gel where bands representing O antigen complementation were detected.
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Figure 19. CLC23 and CLC25 are more sensitive than K56-2 to carbenicillin.
CLC23 grew in medium supplemented with 125 pg/mL (A), while CLC23 and CLC25 
grew in medium supplemented with 250 pg/mL carbenicillin (B and C). Growth was 
monitored in a Bioscreen C automated growth curve reader. Each time point represents 
the mean and standard error of three replicates.
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Figure 20. CLC23 and CLC25 grow poorly in the presence of imipenem. Bacteria 
strains grew in media supplemented with 25 pg/mL (A) or 50 pg/mL (B and C) 
imipenem. Growth of K56-2 and deletions strains was monitored in a Bioscreen C 
automated growth curve reader. Each time point represents the mean and standard error 
of three replicates.
carbenicillin remained for reasons unknown. Other antibiotics outside of the p-Lactam 
family were tested (kanamycin, gentamicin, tetracycline, trimethoprim) but no 
differences were observed between parental and mutant strain sensitivities (data not 
shown). CLC22 grew similarly to parental cells in the presence of each antibiotic tested.
3.2.7. CLC23 does not survive as well as K56-2 at low temperature. One stress that 
stimulates cells to enter a VBNC state is a decrease in temperature. To test if NlpC/P60 
proteins are important for entering a VBNC state in B. cenocepacia, the survival of 
strains K56-2, CLC22 and CLC23 in liquid medium at 4°C and 16 °C were monitored for 
14 days by both CFU enumeration and Live/Dead staining. Survival on solid agar at both 
temperatures was also monitored by CFU enumeration for 7 days. In LB broth at 4°C, all 
strains could not be recovered on solid medium and viability decreased by over 50% in 
one day, and 100% by day 3 (data not shown). In liquid medium at 16°C for 7 days, K56- 
2 viability decreased by 24.8% while CLC23 viability decreased by 37.1% (Fig.21a). 
Recovery of K56-2 on solid medium remained the same over the 14-day incubation 
period, whereas CLC23 CFU counts decreased by over 1 log (Fig.21a). In contrast, 
CLC22 viability and CFU counts did not change significantly over the 14 days (data not 
shown). On solid agar, K56-2 survived better than CLC23 by approximately 2 logs and 5 
logs at 16°C (Fig. 21b) and 4°C (Fig. 21c), respectively, over a 7 day period. After 8 
days, CFU enumeration or fluorescence staining did not detect viable K56-2 and CLC22 
bacteria. CLC22 cultures produced CFU counts comparable to K56-2 (data not shown) 
and remained culturable after 7 days.
3.2.8. CLC22 and CLC23 cells cannot be induced into a VBNC state by osmotic 
shock. Another common method of inducing a VBNC state of bacteria is to ‘shock’ the
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Figure 21. K56-2 survives better than CLC23 at low temperature. Stationary phase 
cells were incubated at 16°C (A) in liquid media for 2 weeks with mild shaking. Growth 
was monitored by plating 0.1 mL aliquots on LB agar and viability was assessed using 
the Live/Dead staining kit. Survival on solid media was monitored by CFU counts over a 
7 day period at both 16°C (B) and 4°C (C).
63
cells by their transfer from normal medium to medium supplemented with high 
concentrations of NaCl. K56-2, CLC22 and CLC23 stationary phase cells were 
transferred to a 7% NaCl solution and culturability was monitored by plating. K56-2 cells 
became unculturable after 3 days while over 70% of cells remained viable based on 
Live/Dead staining (Fig. 22a, 22b). In contrast, CLC22 cells remained culturable for over 
10 days and they did not appear to become less viable (Fig. 22c). After day 1, CLC23 
cells were unculturable and very few cells remained viable. Unfortunately, the amount of 
live cells could not be quantified due to peculiar red/yellow membrane staining (Fig. 22d) 
and therefore results were inconclusive.
3.3 Decreased Intracellular Survival of CLC36, CLC37 and CLC38
B. cenocepacia survives and replicates within epithelial cells and phagocytes. In 
other bacteria, proteins belonging to the NlpC/P60 are important for intracellular survival 
and replication, and deletion of these proteins can sometimes cause diminished virulence 
in vivo. Given the earlier observation that bcal2128 deletion strain cells do not divide 
normally and that they have increased sensitivity to environmental stresses, I 
hypothesized that B. cenocepacia NlpC/P60 mutants strains would not be able to survive 
and replicate ex vivo. Deletion strains of bcal2128 and bcal938 were therefore generated 
in an MH1K background (Table 1) for testing in a macrophage model of infection. The 
resulting strains, CLC36, CLC37 and CLC38, were used to infect Raw 264.7 
macrophages and survival and replication were monitored for 24 hours by CFU 
enumeration. The positive control, MH1K, survived during the 24 hour incubation period 
and replicated by approximately 2 logs. CLC36 cells survived within macrophages but 
they did not replicate as well as parental cells (Fig. 22). CLC37 and CLC38 cells were
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Figure 22. B. cenocepacia cells in a VBNC state. Stationary phase cells were 
transferred to medium containing 7% NaCl and incubated at 37°C for 10 days. K56-2 
cells that had entered a VBNC became round in shape (A). Viability was assessed using 
the Live/Dead staining kit for K56-2 (B), CLC22 (C) and CLC23 (D). Arrows indicate 
examples of a cell that may have entered the VBNC state. Micrographs were taken at 
lOOOx magnification.
also able to survive within macrophages, but their level of replication was significantly 
lower than both CLC36 and MH1K cells (Fig.23).
To address the possibility that the low intracellular pH of macrophages affect B. 
cenocepacia mutant strain survival, growth was monitored for 24 hours in pH 4.5 LB 
medium. K56-2, CLC22 and CLC25 grew normally, where as CLC22 had a slight growth 
defect that could be restored to parental levels by complementation with pCC7 (Fig. 24).
3.4 Enzymatic Activity of B. cenocepacia NlpC/P60 Proteins
3.4.1 BCAL1938 and BCAL2128 localize to the membrane. Based on amino acid 
sequence alignments, BCAL1938 and BCAL2128 are predicted to be lipoproteins that 
function as endopeptidases, cleaving peptide bonds of the PG sacculus. To confirm their 
cellular localization, the full-length genes encoding the two proteins were fused to red 
fluorescent protein (RFP). These constructs were expressed in both B. cenocepacia K56- 
2 and E. coli DH5a and epifluorescence microscopy was used to detect their localization. 
Fluorescence was observed along the periphery of DH5a cells expressing both 
BCAL1938 (Fig. 25b) and BCAL2128 (Fig. 25d) in LB medium. To determine which 
membrane BCAL1938 and BCAL2128 associate with, cell plasmolysis was induced to 
create a more obvious separation between the outer membrane and inner membrane. The 
red fluorescent ring was again visualized for DH5a cells expressing BCAL1938 (Fig.
25c), indicating that the BCAL1938 fusion was associated to the outer membrane. 
Fluorescence was observed in plasmolysis bays of cells expressing BCAL2128 (Fig.
25d), suggesting that BCAL2128 interacts with the inner (cytoplasmic) membrane.
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Figure 23. MH1K survives better than NlpC/P60 mutant strains in Raw 264.7 
macrophages. Macrophages were infected with bacteria at an MOI of 25 for 24 hours. 
Survival within macrophages was determined by CFU enumeration. Data represent two 
independent experiments, both done in triplicate (* P< 0.01 ** P < 0.001).
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Figure 24. CLC23 is more sensitive to low pH than K56-2. Cell cultures grew in pH 
4.5 LB. The pH of the medium was buffered by 100 mM Tris-MES. Growth was 
monitored in a Bioscreen C automated growth curve reader. Each time point represents 
the mean and standard error of three replicates.
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Figure 25. Outer and inner membrane localization of BCAL1938 and BCAL2128.
Full-length genes encoding BCAL1938 and BCAL2128 fused to RFP were expressed in 
E. coli DH5a and visualized by fluorescence microscopy at a magnification of lOOOx. 
Live cells were plasmolyzed in 50% sucrose or left untreated and immobilized on glass 
slides coated with 1% agarose. E. coli cells expressing RFP alone (A) were used as a 
negative control. BCAL1938 fluoresced around the periphery of cells under normal 
conditions (B) and after plasmolysis (C) indicating that it is an outer membrane protein. 
BCAL2128 localized to the inner membrane, as indicated by the florescent ring observed 
under normal conditions (D) and fluorescence in plasmolysis bays after inducing cell 
plasmolysis (E).
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Neither of these two RFP constructs fluoresced well in appropriately transformed K56-2 
cells under either condition.
3.4.2 BCAL1938 and BCAL2128 bind PG in vitro. I hypothesized that the putative 
lytic domain (NlpC/P60) of BCAL1938 and BCAL2128 is located in the periplasm where 
it binds its substrate, PG. To test this, the recombinant proteins were over produced in 
BL21 cells using plasmids pCC28 and pCC22 that provide C-terminal His-tags (Fig. 26). 
The two proteins were isolated and purified using metal affinity chromatography on Ni , 
which effectively removed contaminating proteins and provided sufficient amounts (0.2- 
0.5 mg/ml) of material for characterization (Fig. 27). Pure recombinant proteins were 
incubated with B. cenocepacia PG to perform a PG pull-down assay. After incubation, 
reaction mixtures were centrifuged and the PG pellet was washed and treated with SDS to 
release any bound proteins. The respective fractions were analyzed by SDS PAGE and 
Western blot (Fig 28). Both proteins were detected in the SDS fractions, but not in the 
supernatant or wash fractions, indicating that they were adsorbed to the PG pellet and 
thus able to bind to insoluble PG in vitro.
3.4.3. BCAL1938 and BCAL2128 degrade PG in vitro. To confirm the function of 
predicted NlpC/P60 domains bcaI1938 and bcal2128, the purified recombinant proteins 
were subjected to zymography using insoluble B. cenocepacia PG as substrate. Following 
electrophoresis and renaturation of proteins (by removal of SDS), a zone of clearing was 
observed at the same migration point of both recombinant BCAL1938 and BCAL2128 
(Fig. 29a), signifying that they are able to degrade PG in vitro. The standard 
turbidometric assay was not sensitive enough to detect protein activity, so a more 
sensitive assay was performed involving labeled PG. Insoluble B. cenocepacia PG was
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Figure 26. Schematic representation of predicted domains of BCAL1938 and 
BCAL2128. The blue boxes indicate predicted signal peptide sequences and the purple 
boxes represent the NlpC/P60 domain. Poly His tags were fused to the C-terminus of 
each construct for protein detection. The ‘BCAL2128t’ construct was cloned into pet28a 
(+), resulting in pCC22, and the ‘BCAL1938t’ construct was cloned into pet28a (+) to 
make pCC28.
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Figure 27. SDS-PAGE and Western blot analysis of BCAL1938 and BCAL2128.
Truncated genes not expressing signal peptides (BCAL1938t and BCAL2128t) were 
cloned into pet28a(+) plasmid and overexpressed in BL21 (DE3) competent cells. 
Recombinant proteins were purified by affinity chromatography using Ni - charged 
Sepharose. Lane 1-4, the cleared lysate, flow through , washes and 250 mM imidazole 
elution fraction of BCAL2128, respectively, and lanes 5-8, the same order of collected 
fractions for BCAL1938. BCAL2128 was detected by Western blot using rabbit anti-His 
antibodies and BCAL1938 was detected using mouse anti-His antibodies.
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Figure 28. Recombinant BCAL1938 and BCAL2128 bind PG in vitro. Purified B. 
cenocepacia strain K56-2 PG was combined with 15 fig of purified recombinant protein 
and incubated for one hour at 4°C. Western blots show that BCAL2128 (A) and 
BCAL1938 (B) are not detected in the supernatant [S] after centrifugation with or 
without PG. Proteins were also not detected in the wash fraction [W]. The recovered PG 
pellet was treated with 4% SDS solution [T] to release bound protein from the PG.
pre-labeled with FITC and then incubated with recombinant protein for 3 days. As a 
negative control, and to account for any spontaneous release of label during the course of 
the experiment, labeled PG was incubated in the absence of added proteins. FITC was 
present in the supernatant after centrifugation (Fig. 29b) indicating that PG cleavage had 
occurred with both proteins. No synergistic PG cleavage was observed when both 
proteins were incubated together (data not shown).
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3.5 Attempts to resuscitate VBNC bacteria with BCAL1938, BCAL2128, and two 
putative RPF’s
Although there is no evidence to date that NlpC/P60 proteins can resuscitate 
VBNC on their own, BCAL1938 and BCAL2128’s ability to stimulate growth of VBNC 
B. cenocepacia were tested. In addition, two B. cenocepacia homologs (BCAL1952 and 
BCAL2115 A) of the only characterized Gram-negative RPF were purified (Fig. 30) and 
tested for their ability to resuscitate VBNC cultures alone, and in combination with 
BCAL1938 and BCAL2128. Osmotic shock-induced VBNC B. cenocepacia K56-2 
cultures were incubated with recombinant proteins and re-initiation of growth was 
monitored turbidometrically for 7 days. Under the conditions tested, no growth was 
observed for any of the proteins or protein combination treatments. The supernatant of 
actively growing B. cenocepacia cells was used as a positive control and this was able to 
resuscitate the VBNC culture (data not shown) after 2 days. VBNC cells grown in LB 
alone were used as a negative control.
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Figure 29. Recombinant BCAL1938 and BCAL2128 degrade PG in vitro. (A) 
Zymography of purified recombinant proteins electrophoresed in an SDS-polyacrylamide 
gel co-polymerized with 0.1% PG. 10 pg of BCAL2128 and BCAL1938 were incubated 
in renaturing buffer for 2 days at 37°C and stained with Methylene Blue dissolved in 
0.1 % KOH. Zymograph image colours were removed, the image was inverted, and the 
contrast was increased to better visualize the zones of clearing. (B) FITC-release assay.
10 pg of lysozyme or 20 pg of recombinant purified protein was incubated with a 0.4 
mg/mL PG solution for 3 days at 37°C. The extent of hydrolysis was determined by 
measuring the amount of soluble FITC- PG remaining in the supernatant after 
centrifugation, and thus released during hydrolysis of the insoluble substrate. Buffer 
alone was used to determine background release and values were subtracted from final 
values. Data are representative of 3 independent experiments each done in duplicate.
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Figure 30. SDS-PAGE analysis of purified putative B. cenocepacia RPFs.
BCAL2115A and BCAL1952 were over-produced in BL21 cells and purified using Ni 
charged Sepharose. Lane 1, BCAL2115A cleared lysate fraction; lane 2, BCAL2115A 
flow through fraction; lane 3, BCAL2115A elution fraction; lane 4, BCAL1952 cleared 
lysate fraction; and lane 5, BCAL1952 elution fraction.
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Chapter 4: Discussion
Changes in the environment can be detrimental to bacteria. However, bacteria 
sense environmental changes and adapt to specific stress conditions. Adaptation 
responses involve modification of the cell wall, sometimes for the purpose of creating an 
inert system that sustains bacterial survival and provides increased tolerance to harsh 
conditions. My research has shown that BCAL1938 and BCAL2128 are B. cenocepacia 
autolysins (cell wall lytic enzymes) required for normal cell division and are important 
for cell wall remodeling processes involved in adaptation responses to stress conditions. 
These enzymes belong to the NlpC/P60 endopeptidase family, which in other bacteria 
have been linked to resuscitation of dormant bacterial cells (66, 67). Thus, the study and 
characterization of these proteins in B. cenocepacia could provide further insight into Bcc 
pathogenesis and persistence in infected hosts.
4.1 NlpC/P60 Enzyme Involvement in Cell Division
Although both bcall938 and bcal2128 are not essential for B. cenocepacia 
survival, cells impaired in BCAL2128 production displayed abnormal cell division and 
had irregular cell morphology. During exponential growth, CLC23 cells appeared 
swollen and frequently remained connected together by the septum. Thus, these cells 
either formed long chains or were clustered together in what appears to be a clump of 
cells that partitioned at non-linear division planes. However, by stationary phase most of 
these cells lost the aggregation state, suggesting possible compensatory mechanisms at 
play. This is a likely scenario as CLC25 cells have a more extreme phenotype, degenerate
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growth, and do recover after 24 hours. Furthermore, réintroduction of BCAL1938 into 
CLC25 cells partially restores cell division and suggests that there might be some level of 
redundancy in function between the two enzymes.
4.2 NlpC/P60 Enzyme Involvement in Adaptation
4.2.1 Importance of BCAL2128 during conditions of stress. It is very likely that 
BCAL2128 is an important enzyme during B. cenocepacia adaptation responses as strains 
not expressing BCAL2128 are highly susceptible to conditions that destabilize the cell 
wall. CLC23 and CLC25 strains were unable to grow in medium supplemented with 3% 
NaCl which indicates that the cell wall of these cells is comprised and intolerant to 
increased osmotic pressure in the environment. VBNC bacteria are often discovered in 
high saline environments [94] and high osmotic pressure is frequently used to induce 
VBNC in vitro [31, 49]. Parental, but not CLC23 and CLC25, cells could be induced to 
enter a VBNC state in this manner, which implies that typical cell wall remodeling 
processes are hindered for B. cenocepacia when BCAL2128 is not being expressed. This 
view is also supported by observations made for CLC23 cells growing at non-optimal 
temperatures. CLC23 did not survive well at low temperatures and growth could not be 
recovered in the same manner as parental strain cells. As low temperatures frequently 
induce cells to enter a VBNC state [49], it is evident that BCAL2128 is important for 
long term viability of B. cenocepacia.
CLC23 and CLC25 strains were also unable to grow in the presence hydrogen 
peroxide at concentrations that sustained parental cell growth. This surprising phenotype
could be the result of damaged cell envelope structures, resulting in improper insertion 
and/or formation of enzyme complexes known to be important for resistance against 
oxidative stress. Lack of BCAL2128 expression could cause drastic structural changes to 
the cell wall that no longer permit enzymes to function properly and thus have a 
secondary effect on resistance to oxidative stress. B. cenocepacia has several mechanisms 
to resist oxidative killing including production of catalase, peroxidase, and superoxide 
dismutase [95]. Furthermore, loss of function of these enzymes decreases B. 
cenocepacia’ s ability to survive within macrophages [96, 97].
Unfortunately, the exact nature of the cell wall damage that appears to exist in 
CLC23 and CLC25 remains unknown. This damage could involve one or more 
possibilities but it is clear that the cell membrane of CLC23 and CLC25 is susceptible to 
perturbation. Unlike wild-type cells, both strains were unable to grow in low 
concentrations of SDS detergent, suggesting that their cell envelope is more permeable 
compared to wild-type cells. Again, this could be a reflection of poor cell wall stability, 
possibly due to inadequate structural protein functions. However, CLC23 and CLC25 
cells did not exhibit drastic LPS composition differences, and CLC23 cells did not lose 
resistance to polymyxin, indicating that some cell wall processes are still able to function 
as normal.
The increased sensitivity of CLC23 and CLC25 to some ß-Lactams is of clinical 
significance. ß-Lactam antibiotics are stereochemically related to the substrate used for 
peptide cross-linking processes that occur during the final step of PG biosynthesis. This 
group of antibiotics bind to the transpeptidase and carboyxpeptidase enzymes that are 
involved in these processes. Carbenicillin is a broad-spectrum carboxypenicillin and
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imipenem is a broad-spectrum carbapenem. Both were prevent normal growth of CLC23 
and CLC25 strains, and imipenem inhibited growth at concentrations less than half of the 
MIC for B. cenocepacia. Such observations imply that either the composition of the cell 
wall of CLC23 and CLC25 is altered in such a way that permits increased susceptibility 
to these antibiotics, or that the function of antibiotic resistance mechanisms (e.g. |3 
Lactamase activity) has been affected. Both strains did not lose resistance to ampicillin or 
methicillin, suggesting that the spectrum of activity, stability, and toxicity of the 
antibiotic are significant factors for B. cenocepacia resistance to (3-Lactam antibiotics.
4.2.2 Importance of BCAL1938 for O antigen synthesis. B. cenocepacia cells not 
expressing BCAL1938 were sensitive to polymyxin B. Polymyxin acts like a detergent 
by interacting with LPS on the outer membrane. Normally, Bcc are highly resistant to 
polymyxin, partially due to a Lipid A modification where 4-amino-4-deoxy-L-arabinose 
(Ara4N) replaces Lipid A phosphate residues, a modification that is dispensable for many 
bacteria but essential for B. cenocepacia survival [10, 84]. As no other growth phenotype 
was observed for CLC22, it was hypothesized that the LPS structure must be different for 
B. cenocepacia cells that lack BCAL1938 activity. It is evident that loss of BCAL1938 
production prevents bacteria from linking several O antigen repeats together, resulting in 
a ‘deep rough’ phenotype characterized by a predominance of single O antigen repeats 
attached to the Lipid A core. It is unclear as to whether the observed differences are due 
to BCAL1938’s involvement in LPS biosynthesis, or a secondary effect where the inner 
membrane stability is severely compromised and is preventing the activity of proteins 
normally involved in synthesis and ligation of O antigen to the Lipid A core. The latter is 
an unlikely scenario, as the BCAL2128 mutant appears to have a greater compromise in
membrane stability, and yet has an unaltered LPS profile. Furthermore, CLC22 was not 
affected by SDS, suggesting that polymyxin sensitivity is likely attributed to the absence 
of charged molecules on the LPS structure, and not a compromised cell wall. Lastly, 
BCAL1938 is located three genes downstream of the essential aminoarabinose cluster on 
chromosome one [84], and therefore has the potential to be involved in Ara4N 
biosynthesis and LPS modification. For example, it is conceivable that BCAL1938 is 
important for transport of Ara4N-LPS through the PG layer before insertion into the outer 
membrane. Yet, BCAL1938 is not essential for B. cenocepacia survival and, in fact, 
CLC22 cells often survive better than parental cells under conditions of stress, so some 
level of Ara4N synthesis and LPS modification must be occurring. Thus, in general this 
study revealed clear differences between the LPS profiles of CLC22, CLC25, and 
parental cells, but the interpretation of results at this point is uncertain.
CLC22 and CLC25 LPS profiles could only be partially complemented by 
BCAL1938 expression from a plasmid, as very little polymeric O antigen was restored in 
these cells. However, there is still some level of complementation occurring from pCC19, 
and not pCC7, which indicates that loss of BCAL1938 is responsible for the altered LPS 
structure. Furthermore, independent clones not expressing BCAL1938 showed the same 
LPS profile, eliminating the possibility that other neighboring genes were disrupted 
during mutagenesis.
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4.3 NlpC/P60 Enzyme Involvement in Intracellular Survival
B. cenocepacia strains not expressing BCAL1938 and/or BCAL2128 were unable 
to replicate within macrophages at the same rate as parental K56-2 cells. Of the three 
deletion strains, the single deletion strain for BCAL1938 (CLC36) replicated the most, 
followed by the single deletion strain for BCAL2128 (CLC37) and the double deletion 
strain (CLC38) hardly replicated at all. Intracellular survival was only determined after 
24 hours, so it is unknown as to what proportion of mutants actually survived 
intracellularly and continued to replicate, or whether the majority of the cells did survive 
but instead terminated cell replication and became inert. It is likely that the poor 
replication rate of CLC38 is a reflection of reduced bacterial survival as this study has 
shown that under normal culturing conditions B. cenocepacia strains lacking expression 
of both BCAL1938 and BCAL2128 become less viable after 24 hours. CLC37 and 
CLC38 poor survival is most likely due to increased susceptibility to plasmolysis due to 
comprised cell wall structures. In addition, CLC38 is sensitive to reactive oxygen species 
and does not produce polymeric O antigen, both previously mentioned to be important for 
survival in macrophages.
4.4 Localization and Functional Analysis of NlpC/P60 Enzymes
Using epifluorescence microscopy, this study has shown that BCAL2128 and 
BCAL1938 are proteins that interact with the inner membrane and outer membrane, 
respectively. These results are in agreement with studies done on P. aeruginosa 
lipoprotein signal peptide sequences and how the amino acid positioning after the
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predicted signal peptide cleavage site is a good indication of whether the protein localizes 
to the inner or outer membrane [98].
Both proteins bound and cleaved PG fragments in vitro, confirming their 
predicted PG degradation activity. However, the assays used in this study are for 
demonstration of PG lysis in general, and thus the predicted endopeptidase activity of the 
NlpC/P60 domain is still not confirmed. Nonetheless, the level of PG cleavage detected is 
comparable with other NlpC/P60 enzymes from other organisms (25,63,68-71,99). 
Therefore, it is probable that BCAL2128 and BCAL1938 localize to the periplasm where 
they interact with the inner and outer membrane of the cell wall, respectively, bind PG, 
and cleave the garnma-D-g/Mtamy/-(L)mesc>-diaminopimelic-acid peptide bonds that link 
the glycan chains together (Fig. 2).
Whereas BCAL1938 and BCAL2128 do not require other proteins to function, 
both proteins are not able to resuscitate VBNC cultures on their own. This is consistent 
with other known endopeptidases of this family that interact with RPF proteins [63, 68, 
99]. Therefore, as seen with other bacteria, BCAL2128 and BCAL1938 may interact with 
unknown B. cenocepacia RPFs which would result in synergistic PG cleavage and 
possibly the production of released muropeptides. This process has been linked to 
resuscitation of B. subtilis spores, where serine/threonine protein kinase receptors bind to 
extracellular muropeptides (most likely at the stem peptide region) and induce a signal 
cascade that ultimately results in germination of spores [100]. Although muropeptide 
receptors have yet to be identified for Gram-negative bacteria, the supernatant of active 
bacterial cultures is frequently used to reinitiate growth of VBNC Gram-negative cells, 
suggesting that unknown secreted factors are involved in the resuscitation process [62,
101, 102]. Thus, the PG lytic activity of BCAL1938 and BCAL2128 may be combined 
with the activity of RPF proteins in B. cenocepacia and the cleavage product could 
initiate growth of bacterial cells from a ‘dormant’ or ‘non growth’ state. Another 
possibility is that BCAL1938 and BCAL2128 lytic activity is required, along with other 
autolysins, for specific cell wall remodeling processes that are critical for entry or exit of 
from inert bacterial states. As stated previously, modification of the PG layer of bacterial 
cell walls is usually required for bacteria to exist in a VBNC state (26,49,50), and it is 
possible that NlpC/P60 enzymes are suited for interaction of only modified PG 
structures.
4.5 Concluding Remarks
This study has revealed that the two NlpC/P60 lipoproteins, BCAL1938 and 
BCAL2128, are autolysins required for normal cell division and are therefore important 
for cell wall remodeling processes involved in adaptation to changes in environmental 
conditions. When bcal2128 is not expressed, B. cenocepacia has abnormal cell division 
and increased sensitivity to osmotic pressure, oxidative stress, detergent, and some p- 
Lactam antibiotics. The loss of bcall938 expression renders cells sensitive to polymyxin 
and hinders normal O antigen synthesis. Interestingly, bcal2128 deletion strains do not 
enter an induced VBNC state and instead become less viable over time. Similarly, cells 
that do not express bcall938 also do not readily enter a VBNC state but, in context to 
bcal2128, they continue to grow and survive longer than parental cells. Both strains 
however, have poor survival in macrophages. Based on these observations, as well as the
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prediction that both proteins interact with unknown RFP proteins, BCAL2128 and 
BCAL1938 might be involved in adaptation to environmental stresses and entry and/or 
resuscitation from non-growth states. The increased sensitivity to harsh environmental 
conditions, deep rough LPS phenotype, and poor replication (and survival) in 
macrophages could indicate that these mutant strains have poor survival and loss of 
persistence in host cells. Therefore, future work could potentially employ BCAL2128 and 
BCAL1938 as novel targets for antimicrobial drug development, provide further insight 
into virulence strategies used by B. cenocepacia in CF patients, and possibly be used to 
test the hypothesis that Burkholderia species are able to cause latent infections.
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